SEC Form 4 · Rule 10b5-1 trading plans
Roivant Sciences Ltd. (ROIV)
- 8Trades filed under a plan
- 1Plan adoption dates stated
- 8Quarterly results prints on file
- 0Trades in the days before a print
In the 2025 filing year, Roivant Sciences Ltd. filed 4 Form 4 statements whose footnotes name a Rule 10b5-1 trading plan, by 1 reporting owner, covering 8 transactions filed under those plans and 2,661,000 shares. 4 of those filings carry the SEC's own AFF10B5ONE adoption flag; the other 0 name a plan in a footnote and carry no flag. 8 results prints are on file in the same window, which is what makes the interval below measurable.
Trades filed under a plan in Roivant Sciences Ltd. 8
- Venker Eric — 2025-01-21 · S · 100,000 shares
- Venker Eric — 2025-03-20 · S · 315,522 shares
- Venker Eric — 2025-03-24 · S · 434,478 shares
- Venker Eric — 2025-08-20 · S · 100,000 shares
- Venker Eric — 2025-09-19 · S · 683,818 shares
- Venker Eric — 2025-09-22 · S · 316,182 shares
- Venker Eric — 2025-09-22 · S · 100,000 shares
- Venker Eric — 2025-09-23 · S · 611,000 shares
Plan adoption dates stated in Roivant Sciences Ltd. 1
- 2024-06-25 — stated in 4 filings
Quarterly results prints on file in Roivant Sciences Ltd. 8
- 2025-02-10
- 2025-05-29
- 2025-08-11
- 2025-11-10
- 2026-02-06
- 2026-04-02
- 2026-05-20
- 2026-08-06
Trades in the days before a print in Roivant Sciences Ltd. 0
- 20 days before the 2025-02-10 print — 2025-01-21 · S · Venker Eric · 100,000 shares
- 48 days before the 2025-11-10 print — 2025-09-23 · S · Venker Eric · 611,000 shares
- 49 days before the 2025-11-10 print — 2025-09-22 · S · Venker Eric · 316,182 shares
- 49 days before the 2025-11-10 print — 2025-09-22 · S · Venker Eric · 100,000 shares
- 52 days before the 2025-11-10 print — 2025-09-19 · S · Venker Eric · 683,818 shares
- 66 days before the 2025-05-29 print — 2025-03-24 · S · Venker Eric · 434,478 shares
- 70 days before the 2025-05-29 print — 2025-03-20 · S · Venker Eric · 315,522 shares
- 82 days before the 2025-11-10 print — 2025-08-20 · S · Venker Eric · 100,000 shares
Interval to the next reported results date
For each transaction filed under a plan, the days between the transaction date and the company’s next results print. These are the dates the filings state, printed as an interval; the page draws no conclusion from them.
- 0Within 5 days of a print
- 0Within 10 days of a print
- 20Shortest interval, in days
- 0Trades with no later print on file
Adoption dates, as the filings state them
- 2024-06-25 stated in 4 filings
As the filings state it: “10b5-1 trading plan adopted on June 25, 2024”
Reported results dates on file
- 2025-02-10
- 2025-05-29
- 2025-08-11
- 2025-11-10
- 2026-02-06
- 2026-04-02
- 2026-05-20
- 2026-08-06
A proxy statement is on file for this company in the same window, which is where a company states its own trading policy.
Other companies with plan records
- BRISTOL MYERS SQUIBB CO 1
- FMC CORP 2
- ELI LILLY & Co 4
- ABEONA THERAPEUTICS INC. 2
- HEXCEL CORP /DE/ 2
- TEVA PHARMACEUTICAL INDUSTRIES LTD 12
- Lifevantage Corp 1
- IONIS PHARMACEUTICALS INC 29
- VERTEX PHARMACEUTICALS INC / MA 22
- ARROWHEAD PHARMACEUTICALS, INC. 9
Order the document
Every company with plan records →
Form 4 statements and their footnotes from the SEC’s EDGAR full-text search, and this company’s results dates, industry classification and state of incorporation from the SEC submissions API. The page prints the dates the filings state and the interval between them; it draws no conclusion from them.